Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Posts Tagged ‘charles river’

Charles River Laboratories Adds Virginia M. Wilson to Board of Directors

Posted by fidest press agency su venerdì, 4 ottobre 2019

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Virginia M. (Gina) Wilson, the recently retired Senior Executive Vice President and Chief Financial Officer of Teachers Insurance and Annuity Association of America (TIAA), to its Board of Directors. Ms. Wilson’s extensive financial management experience across multiple industries will enhance the strategic and financial advisory expertise of Charles River’s Board of Directors. As a member of the Board, she will serve on the Audit Committee and the Corporate Governance and Nominating Committee.
“Gina Wilson’s diverse experience across multiple industries will enhance the financial acumen and oversight of Charles River’s Board, in support of our broader strategy and focus on driving profitable growth,” said James C. Foster, Chairman, President and Chief Executive Officer of Charles River. “Ms. Wilson brings highly valuable knowledge and experience in managing the Finance organizations of growing businesses, strategically allocating capital, and driving operating efficiency that will complement the combined skills and experience of our current directors. She will also help ensure continuing success of the Corporate Governance and Nominating Committee’s commitment to developing the diversity of skills, experience, and perspectives the Board will need to successfully guide our global organization. We look forward to working with Gina and her contributions to the continued, long-term success of Charles River.”
Ms. Wilson has more than 30 years of financial management experience overseeing the accounting, actuarial, tax, and financial planning and reporting functions at large, multinational organizations. Prior to retiring in March 2019, she was Senior Executive Vice President and Chief Financial Officer of TIAA, where she was responsible for leading the Fortune 100 company’s finance and actuarial functions, as well as overseeing its insurance company general account, corporate real estate, and sourcing. Prior to joining TIAA in 2010, Ms. Wilson served as Executive Vice President and Chief Financial Officer of Wyndham Worldwide Corporation, leading Wyndham’s finance and technology organizations following its spin-off from Cendant Corporation in 2006. Previously, she served as Cendant’s Executive Vice President and Chief Accounting Officer and also served as Senior Vice President and Corporate Controller of both MetLife, Inc. and Transamerica’s life insurance division. Ms. Wilson began her career at Deloitte, and is a Certified Public Accountant. She is a Board member of Conduent Incorporated and Trustee and Vice Chair of Catholic Charities of the Archdiocese of New York.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Charles River Laboratories to Host 3rd Annual World Congress

Posted by fidest press agency su domenica, 8 settembre 2019

Charles River Laboratories International, Inc. is proud to host the 3rd Annual World Congress: Delivering Therapies to the Clinic Faster on September 23-24, 2019 in Cambridge, Mass. This year’s World Congress will explore novel approaches to drug development that effectively reduce program timelines and accelerate delivery to the clinic.
The World Congress is a two-day scientific program that will illustrate methods to successfully cut time to market and highlight how next generation technologies, like artificial intelligence and genomics, are expediting target discovery and drug development.
Timothy Yu, M.D., Ph.D., Attending Physician, Division of Genetics and Genomics at Boston Children’s Hospital, Associate Member of the Broad Institute, and Assistant Professor in Pediatrics at Harvard Medical School, will discuss the accelerated development of milasen as an example of truly individualized genomic medicine.
Allyson Berent, DVM, DACVIM, Chief Operating Officer of GeneTx Biotherapeutics and Chief Science Officer of the Foundation for Angelman Syndrome Therapeutics, will share her personal journey from veterinary specialist to CSO of a non-profit and co-founder of a biotherapeutic company when her infant daughter was diagnosed with a random, rare, neurogenetic disorder called Angelman syndrome.
On September 23, 2019, the World Congress will host a panel to discuss how artificial intelligence (AI) can be applied in drug discovery. Moderated by Carey Goldberg, Editor of WBUR’s CommonHealth, panelists include Liam Loscalzo of nFerence and David Clark of Charles River, among others. The panel will explore how the industry can quantify the impact of AI on drug discovery, what the real world applications of AI may be, and how the field may advance. Tuesday’s panel discussion will focus on the use of genomics data and will be moderated by Martin Mackay, Ph.D., co-founder of Rallybio and member of Charles River’s Board of Directors.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Charles River Receives WealthBriefing Asia ‘Best Portfolio Management’ Award for 2018

Posted by fidest press agency su venerdì, 8 giugno 2018

Charles River Development has won “Best Portfolio Management Solution” at this year’s WealthBriefing Asia Awards. Presented on 31st May in Singapore, this is the second wealth management award this year recognising the Charles River Investment Management Solution (Charles River IMS). These awards recognise companies, teams and individuals the judges consider having demonstrated innovation and excellence during 2017. “The wealth management industry globally is undergoing significant change, and firms are increasingly turning to technology to help meet competitive and regulatory challenges,” said Cameron Field, Asia Pacific Managing Director, Charles River. “We are seeing more commonality between wealth and institutional requirements, and our solution provides the capabilities and flexibility to support both, so firms can achieve much higher productivity and significant cost savings by managing all of their products and business lines on a single platform.”Charles River’s wealth management solution supports a broad range of investment products across the entire investment lifecycle. From model management, asset allocation, and risk, through to trading, settlement and position keeping, Charles River IMS helps firms increase efficiency and reduce cost and risk by consolidating disparate systems.Charles River has won numerous awards for portfolio management, trading and compliance. In addition to being named ‘Best Portfolio Management Solution’ at the WealthBriefing Awards in Geneva this February, Charles River IMS was also named “Best Buyside Compliance Product” at the Buy-Side Technology Awards 2017, December, 2017.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »